6-64591961-G-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001142800.2(EYS):c.3906C>A(p.His1302Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000279 in 1,507,078 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H1302R) has been classified as Uncertain significance.
Frequency
Consequence
NM_001142800.2 missense
Scores
Clinical Significance
Conservation
Publications
- EYS-related retinopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- retinitis pigmentosaInheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- retinitis pigmentosa 25Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001142800.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| EYS | NM_001142800.2 | MANE Select | c.3906C>A | p.His1302Gln | missense | Exon 26 of 43 | NP_001136272.1 | ||
| EYS | NM_001292009.2 | c.3906C>A | p.His1302Gln | missense | Exon 26 of 44 | NP_001278938.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| EYS | ENST00000503581.6 | TSL:5 MANE Select | c.3906C>A | p.His1302Gln | missense | Exon 26 of 43 | ENSP00000424243.1 | ||
| EYS | ENST00000370621.7 | TSL:1 | c.3906C>A | p.His1302Gln | missense | Exon 26 of 44 | ENSP00000359655.3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152000Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00 AC: 0AN: 124052 AF XY: 0.00
GnomAD4 exome AF: 0.0000288 AC: 39AN: 1355078Hom.: 0 Cov.: 34 AF XY: 0.0000347 AC XY: 23AN XY: 663250 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152000Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74242 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
EYS-related disorder Uncertain:1
The EYS c.3906C>A variant is predicted to result in the amino acid substitution p.His1302Gln. This variant has been reported as a complex allele (i.e. in cis) with the nonsense variant c.9405T>A (p.Tyr3135*); both variants were in the homozygous state in an individual with retinitis pigmentosa (Messchaert et al. 2018. PubMed ID: 29159838). This variant has not been reported in isolation from the nonsense variant. This variant is reported in 0.0062% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.
not provided Uncertain:1
This sequence change replaces histidine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1302 of the EYS protein (p.His1302Gln). This variant is present in population databases (no rsID available, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with EYS-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at